Financial newsfor AI agents.

Market-moving stories, structured for trading automations. Plug into Claude Desktop, Cursor, or your own agent in minutes.

10,000+

Crawled and deduplicated across the open web. The strongest candidates get a full AI pass with a 1–10 relevance score and per-ticker analysis.

6,900+

Distinct publisher domains scanned in the last 30 days.

<1 in 5

Only the best clear the relevance floor with a verified ticker. The rest is filtered out.

~6 min

Median from EDGAR publication to an enriched, ticker-tagged row, covering insider trades (Form 4), corporate actions (8-K) and foreign issuers' earnings releases (6-K).

All of it can come to you. News alerts land in Telegram, email, or a webhook the moment a story clears your filters, and the tickers, categories, and relevance threshold are yours to set.

Set up alerts

Built for AI agents and trading bots.

$NTICNeutralLow

NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 21, 2026, Sunggyu Lee, Ph.D., a member of the Board of Directors, of Northern Technologies International Corpo

$LHLow

LABCORP HOLDINGS INC. (LH): Regulation FD Disclosure

LABCORP HOLDINGS INC. (LH) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01. Regulation FD Disclosure. On September 21, 2026, the Centers for Medicare & Medicaid Services (“CMS”) released preliminary Clinical Laboratory Fee Schedule payment rates applicable from 2027 through 2029 pursuant to the Protecting Access to Medicare Act (“PAMA”). Labco

$HALOHigh

HALOZYME THERAPEUTICS, INC. (HALO): Entry into a Material Definitive Agreement

HALOZYME THERAPEUTICS, INC. (HALO) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Convertible Notes Indentures On September 22, 2026, Halozyme Therapeutics, Inc. (the “Company,” “we,” “us” or “our”) completed its previously announced sale of $1,500.0 million aggregate principal amount of 1.50% Convertible S

$TLSIHighAI 9/10

TriSalus Life shares surge 29% on FDA device clearance

TriSalus Life Sciences (TLSI) shares rose 29% after receiving FDA 510(k) clearance for TriNav Advance, a new device for its Pressure-Enabled Drug Delivery portfolio. The device expands access to small, distal vessels and supports a broader range of embolization procedures. The company plans a limited market release soon. According to the company, the device enhances its portfolio and enables physicians to optimize therapeutic delivery in complex cases.

$NVDAMed

A top chip stock analyst sees big things for Nvidia, Broadcom. How his case aligns with ours

Bernstein analysts maintain bullish views on Nvidia (NVDA) and Broadcom (AVGO), citing strong growth prospects and attractive valuations. They set price targets of $400 for Nvidia (75% upside) and $575 for Broadcom (58% upside). Both companies trade at lower P/E ratios compared to their 5-year averages, suggesting potential cushion against AI sentiment weakness. Nvidia and Broadcom executives also expressed confidence in sustained AI demand.

$MUMed

Michael Burry Adds to Micron, Palantir, Nebius, SOXX Shorts - Palantir Technologies (NASDAQ:PLTR), Micron

Michael Burry increased short positions in Micron (MU), Nebius (NBIS), SOXX ETF, and Palantir (PLTR). He also added long positions in QXO (QXO), Build-A-Bear (BBW), Sprouts (SFM), Birkenstock (BIRK), and MercadoLibre (MELI). Micron is expected to report Q4 earnings on Sept. 30, with analysts forecasting EPS of $31.30 and revenue of $50.62B, according to Benzinga.

The same feed, as an API.

The same scored news feed that powers AlphAI is available as a REST API, and as an MCP server for Claude Desktop, Cursor, and any other agent host. Articles arrive enriched and linked to tickers in real time.

  • Real-time + historical news
  • Per-ticker filters and search
  • Relevance-scored 1–10
  • Free tier + paid scale

Dropping it into an existing stack? The Python and n8n quick starts are copy-paste.

curl https://api.alphai.io/api/news/ \
  -H "Authorization: Bearer ${ALPHAI_API_KEY}" \
  -G -d "symbol=NVDA"

# → {
#   "results": [{
#     "original": {
#       "title": "Nvidia export curbs tighten...",
#       "summary": "The White House is expected to...",
#       "time_published": "2026-04-18T14:32:00Z"
#     },
#     "enrichment": {
#       "category": "macro",
#       "tickers": ["NVDA"],
#       "relevance_score": 9
#     }
#   }, ...],
#   "next_cursor": "MjAyNi0wNC0xOFQxNDozMjowMHw0Mg=="
# }

Three plans. One feed.

Free reads the feed and probes the APIs. Paid plans drop the ads and scale up the rate.

Free

$0forever
  • Unlimited articles on the website
  • REST + MCP: 20 / min · 100 / day each, 1 API key
  • Sponsored placements visible
Start for free

Basic

$2.99$7.99/month
  • No ads, unlimited watchlist
  • Daily digest of ticker alerts
  • REST API: 60 / min · 10,000 / day, 1 key
  • MCP server: 60 / min · 10,000 / day
Get started

Pro

$9.99$24.99/month
  • Everything in Basic
  • REST API: 150 / min · 100,000 / day, 5 keys
  • MCP server: 150 / min · 100,000 / day + bulk
Get started

Subscribe now and keep this rate for as long as you stay subscribed. We will not raise it for you.

Don’t want to watch the feed? Follow a ticker and we’ll deliver a daily digest of everything that clears your relevance bar, so you don’t have to check back.

Set up alerts